313 filings
DEFM14C
QSAM
QSAM Biosciences, Inc.
11 Apr 24
Information related to merger
7:10am
PREM14C
QSAM
QSAM Biosciences, Inc.
1 Apr 24
Preliminary information related to merger
8:32am
10-K
2023 FY
QSAM
QSAM Biosciences, Inc.
Annual report
20 Mar 24
4:51pm
SC 13D/A
Checkmate Strategic Capital 2, LLC
20 Feb 24
QSAM Biosciences / Checkmate Strategic Capital 2 ownership change
5:19pm
5
Checkmate Strategic Capital 2, LLC
20 Feb 24
QSAM Biosciences / Charles Thomas Paschall ownership change
4:51pm
SC 13G/A
Strategic Planning Assets Ltd
20 Feb 24
QSAM Biosciences / Strategic Planning Assets ownership change
6:09am
SC 13G/A
QSAM
QSAM Biosciences, Inc.
15 Feb 24
QSAM Biosciences / GSB ownership change
9:51pm
4/A
Douglas R Baum
14 Feb 24
QSAM Biosciences / Douglas R Baum ownership change
4:43pm
4/A
QSAM
QSAM Biosciences, Inc.
14 Feb 24
QSAM Biosciences / Christopher M. Nelson ownership change
4:43pm
4/A
Link Charles J. Jr.
14 Feb 24
QSAM Biosciences / Jr. Charles J Link ownership change
4:42pm
4
Douglas R Baum
13 Feb 24
QSAM Biosciences / Douglas R Baum ownership change
4:00pm
4
Christopher M. Nelson
13 Feb 24
QSAM Biosciences / Christopher M. Nelson ownership change
4:00pm
8-K
QSAM
QSAM Biosciences, Inc.
7 Feb 24
QSAM Biosciences Signs Definitive Agreement to be Acquired by Telix Pharmaceuticals
9:56pm
8-K
QSAM
QSAM Biosciences, Inc.
16 Jan 24
Other Events
5:08pm
8-K
QSAM
QSAM Biosciences, Inc.
14 Nov 23
Receives $2 Million Pre-Closing Collaboration and Option Fee
12:00am
10-Q
2023 Q3
QSAM
QSAM Biosciences, Inc.
Quarterly report
13 Nov 23
8:43am
8-K
QSAM
QSAM Biosciences, Inc.
29 Sep 23
Unregistered Sales of Equity Securities
4:51pm
8-K
QSAM
QSAM Biosciences, Inc.
16 Aug 23
QSAM Biosciences Provides Update to Shareholders on Phase 1 Progress and Preliminary Clinical Data
4:00pm
10-Q
2023 Q2
QSAM
QSAM Biosciences, Inc.
Quarterly report
14 Aug 23
4:30pm
4
Adam King
29 Jun 23
QSAM Biosciences / Adam King ownership change
6:14am